Abstract
In comparison with other Canadian provinces and most Western countries, the province of Manitoba maintains a different vaccination policy for hepatitis B. This policy provides selective antenatal screening for hepatitis B in women and an inoculation program for hepatitis B vaccination for fourth-grade pupils. There has been increasing concern for this policy with regard to its influence on secular trends of acute hepatitis B incidence in Manitoba. This created a need to summarise the epidemiological characteristics of hepatitis B virus (HBV) infection in Manitoba and to allocate finances and human resources for future prevention programs. The Cadham Provincial Laboratory in Winnipeg, a Canadian Public Health Laboratory, is responsible for testing all specimens for diagnosis of various common infectious diseases in Manitoba. During the period from 1 January 1992 to 31 December 2003, a total of 285,946 clinical specimens were submitted to this laboratory, which confirmed 310 cases of acute HBV and 7,556 cases of chronic HBV infection. A total of 18,168 individuals were identified as having vaccine-induced immune status. The incidence rate of acute HBV infection has significantly decreased from 6.52/100,000 person-years in 1996 to 0.86/100,000 person-years in 2003. Annual prevalence rates of chronic HBV infection in Manitoba increased slightly from 42.96 cases/100,000 population in 1992 to 71.47 cases/100,000 population in 2003. Incidence rates were generally higher in men than in women at all age groups, with values of 2.65 and 1.65 per 100,000 population, respectively (chi-square=15.768, p value <0.001). The highest incidence rate for both males and females was observed in the age group 30–34 years. The North Eastman and Winnipeg Regional Health Authorities showed significantly higher incidence rates of acute hepatitis B compared with the other nine Regional Health Authorities. Selective hepatitis B vaccination programs for children in Manitoba had achieved the greatest success in the prevention of vertical and horizontal transmission. There is an urgent need to develop cost-effective harm-reduction strategies for hepatitis B prevention among adults (aged 30–34) and groups at risk in Manitoba.
Similar content being viewed by others
References
World Health Organization (1997) The world health report 1997—conquering suffering, enriching humanity. ISSN 1020-3311. World Health Organization, Geneva, pp 88–90
Sweet LE, Brown MG, Lee SH, Liston RM, MacDonald MA, Forward KR (1993) Hepatitis B prenatal screening survey, Nova Scotia, 1990–1991. Can J Public Health 84:279–282
Chernesky MA, Blajchman MA, Castriciano S, Basbaum J, Spivak C, Mahony JB (1991) Analysis of a pregnancy-screening and neonatal-immunization program for hepatitis B in Hamilton, Ontario, Canada, 1977–1988. J Med Virol 35:50–54
Delage G, Montplaisir S, Remy-Prince S, Pierri E (1986) Prevalence of hepatitis B virus infection in pregnant women in the Montreal area. Can Med Assoc J 134:897–901
Minuk GY, Nicolle LE, Postl B, Waggoner JG, Hoofnagle JH (1982) Hepatitis virus infection in an isolated Canadian Inuit (Eskimo) population. J Med Virol 10:255–264
Baikie M, Ratnam S, Bryant DG, Jong M, Bokhout (1989) Epidemiologic features of hepatitis B virus infection in northern Labrador. Can Med Assoc J 141:791–795
Zhang J, Zou S, Giulivi A (2001) Epidemiology of hepatitis B in Canada. Can J Infect Dis 12:345–350
Wong WW, Minuk GY (1994) A cross-sectional seroepidemiologic survey of chronic hepatitis B virus infections in Southeast Asian immigrants residing in a Canadian urban centre. Clin Invest Med 17:443–447
Moses S, Mestery K, Kaita KD, Minuk GY (2002) Viral hepatitis in a Canadian street-involved population. Can J Pub Health 93:123–128
Sekla LH, Hammond G, Stackiw W, Eibisch G, Fast M (1988) Testing pregnant women for HBsAg: a pilot study in Manitoba. Can Dis Wkly Rep 14:137–140
Minuk GY, Zhang M, Wong SG, et al (2003) Viral hepatitis in a Canadian First Nations community. Can J Gastroenterol 17:593–596
Wiebe T, Fergusson P, Horne D, et al (1997) Hepatitis B immunization in a low-incidence province of Canada: comparing alternative strategies. Med Decis Making 17:472–482
Damzani NN (2003) Manual of infectious control procedures, 2nd edn. Greenwich Medical Media Ltd., London, pp 185–202
Atkinson W, Wolfe C (2002) Epidemiology and prevention of vaccine-preventable disease, 7th edn. The Public Health Foundation, Waldorf, MD, USA, p 170
Manitoba Health (2004) Population report: June 1, 2002, Winnipeg, http://www.gov.mb.ca/population/2002, cited 21 Sept 2004
Statistics Canada (2004) Annual demographic statistics, 2003. Catalogue no. 91-213-XPB. Ministry of Industry, Ottawa, p 72
Statistics Canada (2003) Annual demographic statistics, 2002. Catalogue no. 91-213-XPB. Ministry of Industry, Ottawa, pp 36–37
El Saadany S, Gully P, Giulivi A (2002) Hepatitis A, B, and C in Canada – results from the National Sentinel Health Unit Surveillance System, 1993–1995. Can J Public Health 93:435–438
Zou S, Zhang J, Tepper M, Giulivi A (2001) Enhanced surveillance of acute hepatitis B and acute hepatitis C in four health regions in Canada. Can J Infect Dis 12:357–363
Centers for Disease Control and Prevention (2004) Incidence of acute hepatitis B – United States, 1990–2002. MMWR 52:1252–1254
Balogun MA, Ramsay ME, Fairley CK, Collins M, Heptonstall J (1999) Acute hepatitis B infection in England and Wales:1995–1996. Epidemiol Infect 122:125–131
Massari V, Maison P, Desenclos J-C, Flahault A (1998) Six years of sentinel surveillance of hepatitis B in general practices in France. Eur J Epidemiol 14:765–767
Acknowledgements
This study was supported by funds from Manitoba Health and Health Canada. We thank Lisa Sockett for her word processing.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hong, Z., Smart, G., Zaniewski, G. et al. Epidemiological study of hepatitis B virus infection in Manitoba, Canada, 1992–2003. Eur J Clin Microbiol Infect Dis 24, 464–470 (2005). https://doi.org/10.1007/s10096-005-1350-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-005-1350-6